Locate Bio key facts
- Developer of a regenerative medicine platform designed to help surgeons restore patients' lives through research, innovation, and performance.
- Locate Bio’s last known valuation is $43.5M.
- It has raised $37.2M; the latest was Later Stage VC ($11.5M) in May 2024.
- Notable investors include Innovate UK, Mercia Ventures, BGF (Financial Services), Wellcome Trust, Midlands Engine Investment Fund — 7 tracked in total.
- Status: Privately Held (backing).
- ·Watch Locate Bio: the Monday email on marks, rounds and moves
Locate Bio funding rounds
No funding rounds for Locate Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Locate Bio valuation
Locate Bio's last known valuation is $43.5 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Locate Bio investors
7 investors are on record for Locate Bio, including Innovate UK, Mercia Ventures, BGF (Financial Services) and Wellcome Trust.
About Locate Bio
Developer of a regenerative medicine platform designed to help surgeons restore patients' lives through research, innovation, and performance. The company's platform develops thermally activated and injectable scaffolds that solidify within the body and can be used to support tissue growth before degrading away, enabling pharmaceutical delivery, medical devices, and biotechnology companies to provide advanced delivery systems and regenerative matrices.
- Sector
- Healthcare
- HQ
- Nottingham, United Kingdom
- Founded
- 2001
- Employees
- 25
- Website
- locatebio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Locate Bio’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.